Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Collagen diseases
MeSH D003095 - collagen diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D003240:
Connective tissue diseases
0 Companies
0 Drugs
Success rate
D003095:
Collagen diseases
94 Companies
14 Drugs
$
Success rate
D004535:
Ehlers-danlos syndrome
0 Companies
0 Drugs
Success rate
D007627:
Keloid
0 Companies
0 Drugs
Success rate
D009394:
Hereditary nephritis
0 Companies
0 Drugs
Success rate
D010013:
Osteogenesis imperfecta
0 Companies
0 Drugs
Success rate
D016108:
Epidermolysis bullosa dystrophica
1 Company
0 Drugs
Success rate
D017441:
Necrobiotic disorders
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
100
%
1/1
Phase 3
86
%
6/7
Approved:
6
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AbbVie
Dexamethasone
,
Prednisolone
,
Prednisolone tebutate
Alcon Research
Dexamethasone
,
Prednisolone
,
Prednisolone tebutate
Allergan
Cortisone
,
Cortisone acetate
,
Dexamethasone
,
Prednisolone
,
Prednisolone tebutate
Apotex
Dexamethasone
Bausch Health Companies
Dexamethasone
,
Neomycin
,
Polymyxin b
,
Prednisolone
,
Prednisolone tebutate
,
Prednisone
,
Tobramycin
1
2
3
4
5
6
7
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use